Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?

Publication | Closed Access

DOI

Citations

References

2006

Year

Thomas P. Shakespeare, Keith Lim, K.M. Lee, Michael Back, Rahul Mukherjee, Jiandong Lu

International Journal of Gynecological Cancer